Thomas Cannell
Geen lopende functies
Vermogen: 55 135 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Thomas Cannell
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 29 | |
| Subsidiary | Pharmaceuticals: Major | 24 | |
| Public Company | Pharmaceuticals: Major | 24 | |
Merck Canada, Inc.
 Merck Canada, Inc. Drugstore ChainsRetail Trade Part of Merck & Co., Inc., Merck Canada, Inc. is a Canadian biopharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada and is committed to increasing access to healthcare through policies, programs, and partnerships. Merck Canada continues to be at the forefront of research to prevent and treat diseases such as cancer, HIV, and Ebola. The company aspires to be the premier research-intensive biopharmaceutical company in the world. Marwan Akar has been the CEO of the company since 1997.
1
| Subsidiary | Drugstore Chains | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thomas Cannell via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
| University of California, Irvine | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin Doctorate Degree | |
| TREVENA, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO Public Communications Contact Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Comptroller/Controller/Auditor | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | General Counsel Public Communications Contact Corporate Officer/Principal | |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Pharmaceuticals: Major | Director/Board Member General Counsel Director/Board Member | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer Sales & Marketing | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | General Counsel Investor Relations Contact | |
| University of Redlands | College/University | Masters Business Admin Masters Business Admin | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree Doctorate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Graduate Degree | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| UCLA School of Law | College/University | Graduate Degree Graduate Degree | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member | |
| EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Southern Illinois University | College/University | Masters Business Admin Undergraduate Degree | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
PowerVision, Inc.
 PowerVision, Inc. Electronic ComponentsElectronic Technology PowerVision, Inc. develops fluid-controlled intraocular lens. The firm provides FluidVision accommodating intraocular lens technology, which restores the vision of youth to middle aged or elderly individuals affected by presbyopia and cataracts regain to adjust focus for clear vision at all distances. The company was founded by Matthew A. Frinzi, Randy McDonald, and Barry Cheskin in 2002 and is headquartered in Belmont, CA. | Electronic Components | Director/Board Member Chief Executive Officer | |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of Toronto | College/University | Masters Business Admin Corporate Officer/Principal | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
| EQUILLIUM, INC. | Biotechnology | Director/Board Member Director of Finance/CFO |
Statistieken
Internationaal
| Verenigde Staten | 48 |
| Australië | 2 |
| Ierland | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 18 |
| Finance | 4 |
| Electronic Technology | 2 |
Operationeel
| Director/Board Member | 259 |
| Corporate Officer/Principal | 157 |
| Independent Dir/Board Member | 91 |
| Chief Executive Officer | 66 |
| Chairman | 63 |
Sterkste connecties
| Insiders | |
|---|---|
| Eckard Weber | 46 |
| Brian H. Dovey | 40 |
| Daniel Lynch | 32 |
| Louis C. Bock | 27 |
| Wendy Dixon | 25 |
| Jane Henderson | 25 |
| Abbie Celniker | 23 |
| Paul Rothman | 21 |
| Deborah Jorn | 20 |
| Pamela Craig | 20 |
| Peter Honig | 20 |
| David Endicott | 18 |
| Richard Fitzgerald | 17 |
| Mathai Mammen | 16 |
| Stephen Allen Hurly | 16 |
- Beurs
- Insiders
- Thomas Cannell
- Bedrijfsconnecties
